157 related articles for article (PubMed ID: 7615846)
21. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
Deshmukh AR; Dhurat RS; Jerajani HR
Indian J Lepr; 2003; 75(3):209-17. PubMed ID: 15267190
[TBL] [Abstract][Full Text] [Related]
22. Histological assessment of dermal nerve damage occurring during multidrug therapy for leprosy.
Jain M; Singh N; Bhatia A; Arora VK
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):167-71. PubMed ID: 11036497
[TBL] [Abstract][Full Text] [Related]
23. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
[TBL] [Abstract][Full Text] [Related]
24. The cellular content of dermal leprous granulomas: an immuno-histological approach.
Wallach D; Flageul B; Bach MA; Cottenot F
Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):318-26. PubMed ID: 6332791
[TBL] [Abstract][Full Text] [Related]
25. Granulomatous reactivation during the course of a leprosy infection: reaction or relapse.
Trindade MA; Benard G; Ura S; Ghidella CC; Avelleira JC; Vianna FR; Marques AB; Naafs B; Fleury RN
PLoS Negl Trop Dis; 2010 Dec; 4(12):e921. PubMed ID: 21200422
[TBL] [Abstract][Full Text] [Related]
26. Delayed resolution versus treatment failure in PB leprosy patients.
Porichha D
Indian J Lepr; 1998; 70(2):225-7. PubMed ID: 9724864
[No Abstract] [Full Text] [Related]
27. Neuritic leprosy: further progression and significance.
Mishra B; Mukherjee A; Girdhar A; Husain S; Malaviya GN; Girdhar BK
Acta Leprol; 1995; 9(4):187-94. PubMed ID: 8711979
[TBL] [Abstract][Full Text] [Related]
28. A quantitative study of the relationship between systemic and histological parameters of immunity in individual leprosy patients.
Cree IA; Smith WC; Beck JS
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):347-52. PubMed ID: 2198317
[TBL] [Abstract][Full Text] [Related]
29. Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy.
Rea TH; Shen JY; Modlin RL
Clin Exp Immunol; 1986 Aug; 65(2):253-9. PubMed ID: 2431817
[TBL] [Abstract][Full Text] [Related]
30. Response of thickened nerve trunks and skin lesions of leprosy patients to MDT.
Porichha D; Rao AK; Nehemaiah E; Mishra MC
Indian J Lepr; 2011; 83(1):31-5. PubMed ID: 21638981
[TBL] [Abstract][Full Text] [Related]
31. A study on the impact of FD-MDT on 200 leprosy patients.
Vara N; Marfatiya Y
Indian J Lepr; 2005; 77(3):217-27. PubMed ID: 16353520
[TBL] [Abstract][Full Text] [Related]
32. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
33. TH17 cells, interleukin-17 and interferon-γ in patients and households contacts of leprosy with multibacillary and paucibacillary forms before and after the start of chemotherapy treatment.
de Almeida-Neto FB; Assis Costa VM; Oliveira-Filho AF; de Souza Franco E; Tavares Julião de Lima EV; Barros de Lorena VM; Oliveira de Souza VM; de Sousa Maia MB
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1354-61. PubMed ID: 25429820
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of the granuloma fraction in leprosy skin biopsies by planimetry.
Cree IA; McDougall AC; Coghill G; Beck JS
Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):582-6. PubMed ID: 4086920
[TBL] [Abstract][Full Text] [Related]
35. [Leprosy. Pathogenesis--classification--diagnosis--treatment].
Stingl P
Hautarzt; 1990 Mar; 41(3):126-30. PubMed ID: 2188935
[TBL] [Abstract][Full Text] [Related]
36. Sural nerve biopsy in leprosy patients after varying periods of treatment: histopathological and bacteriological findings on light microscopy.
Haimanot RT; Mshana RN; McDougall AC; Andersen JG
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):163-70. PubMed ID: 6539309
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotype of skin lymphocytic infiltrate in patients co-infected with Mycobacterium leprae and human immunodeficiency virus: a scenario dependent on CD8+ and/or CD20+ cells.
Massone C; Talhari C; Talhari S; Brunasso AM; Campbell TM; Curcic P; Cerroni L; Ribeiro-Rodrigues R
Br J Dermatol; 2011 Aug; 165(2):321-8. PubMed ID: 21574977
[TBL] [Abstract][Full Text] [Related]
38. T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies.
Narayanan RB; Bhutani LK; Sharma AK; Nath I
Clin Exp Immunol; 1983 Mar; 51(3):421-9. PubMed ID: 6342880
[TBL] [Abstract][Full Text] [Related]
39. Single-dose treatment for single lesion leprosy; histopathological observations.
Shinde A; Khopkar U; Pai VV; Ganapati R
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):328-30. PubMed ID: 11221099
[No Abstract] [Full Text] [Related]
40. Limitations of clinico-histopathological correlation of skin biopsies in leprosy.
Jha R; Karki S
J Nepal Health Res Counc; 2010 Apr; 8(1):40-3. PubMed ID: 21879013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
